Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Comparison of Qutenza (8% Capsaicin) With a Low-dose Capsaicin for Treatment of Nerve Pain After Surgery

ClinicalTrials.gov ID: NCT04967664

Public ClinicalTrials.gov record NCT04967664. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 3:41 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Interventional, Phase III, Double-blind, Randomized, Controlled, Parallel-group, Multi-site, Clinical Trial Evaluating the Efficacy and Safety of Qutenza® in Subjects With Post-surgical Neuropathic Pain

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is an interventional, Phase III, double-blind, randomized, controlled, parallel-group, multi-site, clinical trial to confirm the efficacy and safety of repeated topical application of Qutenza (capsaicin 8% topical system) versus low-dose capsaicin control (capsaicin 0.04% topical system) in subjects with moderate to severe postsurgical neuropathic pain (PSNP).

Study identification

NCT ID
NCT04967664
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Averitas Pharma, Inc.
Industry
Enrollment
412 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 13, 2021 (Actual)
Primary completion
Aug 28, 2025 (Actual)
Completion
Aug 28, 2025 (Actual)
Last update posted
Sep 21, 2026

2021 – 2025

United States locations

U.S. sites
23
U.S. states
17
U.S. cities
22
Facility City State ZIP Site status
Tucson Orthopaedic Institute Tucson Arizona 85712 —
ILD Research Center Vista California 92009 —
International Spine, Pain, and Performance Center Washington D.C. District of Columbia 20006 —
South Lake Pain Institute Clermont Florida 34711 —
University Clinical Research - DeLand Clinical Research Unit DeLand Florida 32720 —
Florida Research Center, Inc. Miami Florida 33174 —
Clinical Research of West Florida Tampa Florida 33606 —
Drug Studies America Marietta Georgia 30060 —
Rush University Medical Center Chicago Illinois 60612 —
Neuroscience Research Center, LLC Overland Park Kansas 66210 —
Kansas City Bone & Joint Clinic, P.A. Overland Park Kansas 66211 —
Boston Clinical Trials Boston Massachusetts 02131 —
Great Lakes Research Group, Inc. Bay City Michigan 48706 —
Premier Pain Centers Shrewsbury New Jersey 07702 —
Ainsworth Institute of Pain Management New York New York 10022 —
Accellacare Wilmington North Carolina 28401 —
The Center for Clinical Research Winston-Salem North Carolina 27103 —
META Medical Research Institute, LLC Dayton Ohio 45432 —
Main Line Spine King of Prussia Pennsylvania 19406 —
New Phase Research & Development Knoxville Tennessee 37909 —
Expert Pain Houston Texas 77079 —
The University of Texas Health Science Center at San Antonio San Antonio Texas 78229 —
Wasatch Clinical Research, LLC Salt Lake City Utah 84107 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 41 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04967664, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 21, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04967664 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →